SG Americas Securities LLC Increases Stock Position in Select Medical Holdings Corporation $SEM

Posted by George Bondi on Jun 30th, 2026

SG Americas Securities LLC lifted its holdings in Select Medical Holdings Corporation (NYSE:SEM – Free Report) by 543.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 231,988 shares of the health services provider’s stock after buying an additional 195,959 shares during the quarter. SG Americas Securities LLC’s holdings in Select Medical were worth $3,779,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the business. Quarry LP bought a new stake in shares of Select Medical in the 4th quarter worth approximately $26,000. Quantbot Technologies LP bought a new stake in Select Medical in the third quarter worth $27,000. Caitong International Asset Management Co. Ltd bought a new stake in Select Medical in the fourth quarter worth $28,000. Hantz Financial Services Inc. grew its stake in shares of Select Medical by 214.7% in the fourth quarter. Hantz Financial Services Inc. now owns 2,549 shares of the health services provider’s stock worth $38,000 after acquiring an additional 1,739 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its position in shares of Select Medical by 37.8% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock worth $43,000 after purchasing an additional 788 shares during the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Price Performance

SEM opened at $16.54 on Tuesday. Select Medical Holdings Corporation has a 52-week low of $11.65 and a 52-week high of $16.99. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.15 and a current ratio of 1.15. The company’s 50-day simple moving average is $16.51 and its two-hundred day simple moving average is $15.95. The stock has a market capitalization of $2.05 billion, a P/E ratio of 15.60, a P/E/G ratio of 0.95 and a beta of 1.01.

Select Medical (NYSE:SEM – Get Free Report) last posted its earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The company had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period last year, the firm posted $0.44 EPS. The company’s revenue for the quarter was up 5.0% on a year-over-year basis. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, analysts predict that Select Medical Holdings Corporation will post 1.26 EPS for the current year.

Select Medical Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 28th. Stockholders of record on Thursday, May 14th were paid a $0.0625 dividend. This represents a $0.25 annualized dividend and a dividend yield of 1.5%. The ex-dividend date was Thursday, May 14th. Select Medical’s dividend payout ratio is 23.58%.

Wall Street Analyst Weigh In

SEM has been the subject of a number of analyst reports. Mizuho restated a “neutral” rating and set a $16.50 price objective (down from $17.00) on shares of Select Medical in a research note on Tuesday, May 12th. Royal Bank Of Canada reiterated a “sector perform” rating and set a $16.50 price target (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Benchmark lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. Weiss Ratings raised Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, June 4th. Finally, Wall Street Zen lowered Select Medical from a “buy” rating to a “hold” rating in a report on Monday, March 9th. One research analyst has rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Select Medical presently has a consensus rating of “Hold” and an average price target of $15.50.

Check Out Our Latest Research Report on Select Medical

Select Medical Company Profile

(Free Report)

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.